Adam Konopka, PhD
University of Wisconsin, Madison · University of Illinois at Urbana-Champaign
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Adam Konopka, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:22 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05949658 · Rapalog Pharmacology (RAP PAC) StudyUniversity of Wisconsin, Madison · recruiting · Aging · principal investigator
- Ph2NCT05835999 · Everolimus Aging StudyUniversity of Wisconsin, Madison · completed · Aging, Insulin Resistance · principal investigator
- Ph3NCT04264897 · Antecedent Metabolic Health and Metformin Aging StudyOklahoma Medical Research Foundation · completed · Aging, Insulin Sensitivity, Chronic Disease · principal investigator
- N/ANCT03848741 · Independent and Combined Effects of Resistance Exercise Training and β-hydroxy β-methylbutyrate Plus Vitamin DUniversity of Illinois at Urbana-Champaign · unknown · Aging, Skeletal Muscle · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:22 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Safer mTOR inhibition for human geroprotectionU01AG081482 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI Adam R Konopka, Dudley William Lamming · fiscal years 2023 to 2026Named on NCT05949658
- Clinical evaluation of mTORC1 inhibition for geroprotection.U01AG076941 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI Adam R Konopka · fiscal years 2022 to 2024Named on NCT05835999
- Does insulin sensitivity impact the potential of metformin to slow aging?R01AG064951 · NIA · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI Benjamin Francis Miller · fiscal years 2019 to 2024Named on NCT04264897
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.